Consonance Capital Management as of Dec. 31, 2016
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 23 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Clovis Oncology | 13.3 | $121M | 2.7M | 44.42 | |
| Horizon Pharma | 10.3 | $94M | 5.8M | 16.18 | |
| United Therapeutics Corporation (UTHR) | 9.2 | $83M | 581k | 143.43 | |
| Amarin Corporation (AMRN) | 8.5 | $77M | 25M | 3.08 | |
| Mallinckrodt Pub | 6.3 | $58M | 1.2M | 49.82 | |
| Retrophin | 5.8 | $53M | 2.8M | 18.93 | |
| AtriCure (ATRC) | 5.7 | $52M | 2.7M | 19.57 | |
| Globus Med Inc cl a (GMED) | 5.1 | $46M | 1.9M | 24.82 | |
| Ariad Pharmaceuticals | 4.9 | $44M | 3.6M | 12.44 | |
| Mednax (MD) | 4.8 | $44M | 660k | 66.66 | |
| Myriad Genetics (MYGN) | 4.3 | $39M | 2.3M | 16.67 | |
| Merrimack Pharmaceuticals In | 4.1 | $37M | 9.1M | 4.08 | |
| AMAG Pharmaceuticals | 3.9 | $36M | 1.0M | 34.80 | |
| Biosante Pharmaceuticals (ANIP) | 3.3 | $30M | 492k | 60.62 | |
| Array BioPharma | 2.6 | $24M | 2.7M | 8.78 | |
| Pacira Pharmaceuticals (PCRX) | 2.2 | $20M | 632k | 32.30 | |
| Novadaq Technologies | 1.9 | $17M | 2.4M | 7.09 | |
| Acadia Healthcare (ACHC) | 1.9 | $17M | 511k | 33.10 | |
| Vericel (VCEL) | 1.0 | $8.9M | 3.0M | 3.00 | |
| Adma Biologics (ADMA) | 0.7 | $6.5M | 1.3M | 5.12 | |
| Biolase Technology | 0.2 | $2.0M | 1.4M | 1.40 | |
| Seaspine Holdings | 0.1 | $1.0M | 128k | 7.90 | |
| Veracyte (VCYT) | 0.0 | $362k | 47k | 7.74 |
